EXHIBIT 107

 

EX-FILING FEES

 

Calculation of Filing Fee Tables

S-1

(Form Type)

DERMATA THERAPEUTICS, INC.

(Exact Name of Registrant as Specified in its Charter)

Registrant Name in English, if applicable

(Translation of Registrant’s Name into English)

Table 1: Newly Registered and Carry Forward Securities

 

 
1

 

 

Security Type

Security Class Title

Fee

Calculation

or Carry

Forward Rule

Maximum

Aggregate

Offering Price(1)

Fee Rate

Amount of

Registration Fee (2)

Fees to Be Paid

Equity

Common Stock, $0.0001 par value per share (2)(3)

457(o)

$8,000,000.00

$110.20 per $1,000,000

$881.60

Other

Series A Warrants to purchase Common Stock (4)

457(g)

____

____

$0.00

Equity

Common Stock issuable upon exercise of Series A Warrants to purchase Common Stock (2)

457(o)

$8,000,000.00

$110.20 per $1,000,000

$881.60

 

Other

Series B Warrants to purchase Common Stock (4)

457(g)

____

 

 

 

Equity

Common Stock issuable upon exercise of Series B Warrants to purchase Common Stock (2)

457(o)

$8,000,000.00

$110.20 per $1,000,000

$881.60

Other

Pre-Funded Warrants to purchase Common Stock (3)(4)

457(g)

____

____

$0.00

Equity

Common Stock issuable upon exercise of the Pre-Funded Warrants (2)(3)

457(o)

____

____

$0.00

Other

Placement Agent Warrants to purchase shares of Common Stock (4)

457(g)

____

____

$0.00

Equity

Common Stock issuable upon exercise of the Placement Agent Warrants

457(o)

$700,000.00

$110.20 per $1,000,000

$77.14

TOTAL

$24,700,000.00

$2,721.94

TOTAL FEES PREVIOUSLY PAID

$1,840.34

TOTAL FEE OFFSETS

-

NET FEES DUE

$881.60

 

 
2

 

 

(1)

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).

 

(2)

Pursuant to Rule 416(a) under the Securities Act of 1933, this registration statement shall also cover an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions.

 

(3)

The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $8,000,000.00.

 

(4)

No separate registration fee required pursuant to Rule 457(g) under the Securities Act.

 

 
3